Drug class
Complement C5 Inhibitor
Mechanism of action
Complement C5 Inhibitors [MoA]
General use cases
- Hemoglobinuria, Paroxysmal
- adult and pediatric patients 13 years and older with paroxysmal nocturnal hemoglobinuria (PNH) and body weight of at least 40 kg
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
